EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Association of Race and Social Determinants of Health With Exacerbations in Generalized Myasthenia Gravis

Louis Jackson iD, Zhiwen Liu, Jacqueline Pesa iD, Alicia K Campbell iD, Ashley E L Anderson

Muscle & Nerve · 2025

DOI: 10.1002/mus.70022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Muscle & Nerve, 2025. Verfasst von Louis Jackson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Johnson & Johnson, Horsham, Pennsylvania, USA. Hauptthemen laut MEDLINE: Myasthenia Gravis, Racial Groups, Social Determinants of Health. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Johnson and Johnson.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Aims While racial/ethnic disparities exist across many disease states, their influence on the risk of adverse clinical outcomes in large populations of generalized myasthenia gravis (gMG) patients has not been extensively studied. This study assessed the association between race/ethnicity and MG exacerbation risk and examined the potential role of social determinants of health (SDOH).

Methods

This retrospective cohort study utilized data from HealthVerity; a large, de‐identified, US insurance claims database. Eligible patients were adults with gMG (≥ 2 MG diagnosis code claims, excluding patients with only ophthalmologic specialist visits on/before index date). Inverse probability of treatment weighting using baseline variables was constructed with multinomial distribution for race/ethnicity (Asian/Black/Hispanic/White). Incidence rate ratio (IRR) for ≥ 1 MG exacerbation (defined as an inpatient episode with MG as admitting diagnosis) during follow‐up was assessed using a generalized estimating equations model, using “White” as the reference. A subset of patients was linked with SDOH variables by residential ZIP code (income‐per‐capita and percentage of population without health insurance coverage) using the Agency for Healthcare Research and Quality database, and MG exacerbation risk adjusted.

Results

Of 10,981 gMG patients, 5147 had linked SDOH data. Weighted risk of MG exacerbations was significantly higher among Black versus White patients (IRR 1.21; 95% confidence interval 1.05–1.39). The association remained after controlling for income and/or health insurance coverage.

Discussion

Potential racial disparities exist in the occurrence of MG exacerbations. Further investigation of potential drivers is warranted. At‐risk populations should be a focus for healthcare and patient support provision.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myasthenia GravisRacial GroupsSocial Determinants of HealthAdultAgedFemaleHumansMaleMiddle AgedCohort StudiesDisease ProgressionEthnicityRetrospective StudiesUnited StatesWhiteAsianHispanic or LatinoBlack or African American

Stichwörter der Autor:innen

African Americangeneralized myasthenia gravishealth insuranceincomeracial groups

Autor:innen und Institutionen

  • Johnson & Johnson, Horsham, Pennsylvania, USA.
  • Johnson & Johnson, Titusville, New Jersey, USA.
  • Neuromuscular Division, Houston Methodist, Houston, Texas, USA.

ORCID-Profile: Louis Jackson, Jacqueline Pesa, Alicia K Campbell

Förderung

  • Johnson and Johnson

Zitieren

APA

Jackson, L., Liu, Z., Pesa, J., Campbell, A. K., & Anderson, A. E. L. (2025). Association of Race and Social Determinants of Health With Exacerbations in Generalized Myasthenia Gravis. Muscle & Nerve. https://doi.org/10.1002/mus.70022

Vancouver

Jackson L, Liu Z, Pesa J, Campbell AK, Anderson AEL. Association of Race and Social Determinants of Health With Exacerbations in Generalized Myasthenia Gravis. Muscle & Nerve. 2025. doi:10.1002/mus.70022

BibTeX
@article{Jackson2025,
  author = {Jackson, Louis and Liu, Zhiwen and Pesa, Jacqueline and Campbell, Alicia K and Anderson, Ashley E L},
  title = {Association of Race and Social Determinants of Health With Exacerbations in Generalized Myasthenia Gravis},
  journal = {Muscle & Nerve},
  year = {2025},
  doi = {10.1002/mus.70022}
}
Kostenlos starten →